Literature DB >> 6363642

Ameloblastoma of the mandible treated by resection, preservation of the inferior alveolar nerve, and bone grafting.

T C Wu, Z Chen, F C Tian, Q Z Tian, C T You.   

Abstract

The results of five cases of ameloblastoma of the mandible treated by resection, preservation of the inferior alveolar nerve, and immediate bone grafting are reported. The incisions in all cases healed by first intention. Lip sensation on the operated side returned to normal in four to six weeks in four cases and slight numbness persisted to the eighth week in one case. All patients were followed postoperatively for 13-15 years. In one case the tumor recurred in the mucous membrane seven years after surgery at the original intraoral site and invaded the underlying bone graft. The indications and contraindications for surgery and details of the procedures, including measures to prevent recurrence, are presented.

Entities:  

Mesh:

Year:  1984        PMID: 6363642     DOI: 10.1016/0278-2391(84)90318-5

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  3 in total

1.  Wide Excision with Immediate Reconstruction of the Mandible Using Free Fibular Flap in Ameloblastoma of the Mandible-A Need of Time: Our Experience of 37 Cases.

Authors:  Hemant A Saraiya
Journal:  Indian J Plast Surg       Date:  2020-11-24

2.  Ameloblastoma Management: "Horses for Courses" Protocol.

Authors:  Suresh Menon; Veerendra Kumar; S Archana; Priyangana Nath; Satyapriya Shivakotee; Mahbubul Hoda
Journal:  J Maxillofac Oral Surg       Date:  2019-01-23

3.  A Novel Treatment Concept for Advanced Stage Mandibular Osteoradionecrosis Combining Isodose Curve Visualization and Nerve Preservation: A Prospective Pilot Study.

Authors:  Gustaaf J C van Baar; Lars Leeuwrik; Johannes N Lodders; Niels P T J Liberton; K Hakki Karagozoglu; Tymour Forouzanfar; Frank K J Leusink
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.